Seattle Prostate Institute

Appointments 206.386.2356

News & Events

Active Surveillance and Primary Androgen Deprivation

Posted on: 11/01/2009

"Active Surveillance: A Work in Progress Aiming For Optimal Patient Selection" & "Improving Active Surveillance Selection Criteria "MRI Technology Can Lower Gleason Misclassification Rate" (Sept-Oct 2012)
Active Surveillance: Surgical management after active surveillance for low-risk prostate cancer: pathological outcome compared with men undergoing immediate treatment (Jan-Feb 2012)
Active Surveillance and 5-Alpha Reductase Inhibitors (Sept-Oct 2011)

Active Surveillance: A Suggested Patient Selection Guideline (Nov-Dec 2010)

Active Surveillance: Dr Peter Carroll, Professor and Chair of the Department of Urology, UCSF, Reports the Details and Outcomes of Studies at UCSF (Jan-Feb 2010)

Active Surveillance: Encouraging Outcomes from a Large National Study (Jan-Feb 2010)

Active Surveillance: Supplying the Missing Link (Nov-Dec 2009)

Endocrine Therapy, With or Without Radiotherapy in Locally Advanced Prostate Cancer (May-June 2009)

Primary Androgen Deprivation for Prostate Cancer (February 2007)
   
Active Surveillance With Elective Delayed Intervention (July 2005)
   
Expectant Management Of Localized Prostate Cancer With An Intent To Cure: An Oxymoron? (July 2004)

Canary Prostate Active Surveillance Study (PASS) Is Open For Registration (November 2008)

Forthcoming Protocol Combining Active Surveillance And Biomarker Analysis (June 2008)

Back to article

our physicians